We've found
1,978 Psoriasis
clinical trials
We've found
1,978 Psoriasis
clinical trials
Psoriatic Arthritis Clinical Trial
Updated: 12/31/1969
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriatic Arthritis Clinical Trial
Updated: 12/31/1969
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriatic Arthritis Clinical Trial
Updated: 12/31/1969
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriatic Arthritis Clinical Trial
Updated: 12/31/1969
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriatic Arthritis Clinical Trial
Updated: 12/31/1969
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriatic Arthritis Clinical Trial
Updated: 12/31/1969
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriatic Arthritis Clinical Trial
Updated: 12/31/1969
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriatic Arthritis Clinical Trial
Updated: 12/31/1969
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriatic Arthritis Clinical Trial
Updated: 12/31/1969
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriatic Arthritis Clinical Trial
Updated: 12/31/1969
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriatic Arthritis Clinical Trial
Updated: 12/31/1969
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriatic Arthritis Clinical Trial
Updated: 12/31/1969
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriatic Arthritis Clinical Trial
Updated: 12/31/1969
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Updated: 12/31/1969
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Updated: 12/31/1969
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Dermatology / Plastic Surgery, Otolaryngology Clinical Trial
Updated: 12/31/1969
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Dermatology / Plastic Surgery Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Dermatology / Plastic Surgery Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Dermatology / Plastic Surgery Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate to Severe Plaque Psoriasis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate to Severe Plaque Psoriasis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate to Severe Plaque Psoriasis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Neurology, Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriatic Plaque Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriatic Plaque Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials

Dermatology / Plastic Surgery Clinical Trial
Updated: 12/31/1969
A Study to Assess the Safety, Tolerability and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Dermatology / Plastic Surgery Clinical Trial
Updated: 12/31/1969
A Study to Assess the Safety, Tolerability and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Dermatology / Plastic Surgery Clinical Trial
Updated: 12/31/1969
A Study to Assess the Safety, Tolerability and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Dermatology / Plastic Surgery Clinical Trial
Updated: 12/31/1969
A Study to Assess the Safety, Tolerability and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 in Subjects With Moderate to Severe Psoriasis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 in Subjects With Moderate to Severe Psoriasis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 in Subjects With Moderate to Severe Psoriasis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Atopic Dermatitis Clinical Trial
Updated: 12/31/1969
Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Clinical Trial
Updated: 12/31/1969
This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Plaque Psoriasis Clinical Trial
Updated: 12/31/1969
A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Plaque Psoriasis Clinical Trial
Updated: 12/31/1969
A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Plaque Psoriasis Clinical Trial
Updated: 12/31/1969
A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Plaque Psoriasis Clinical Trial
Updated: 12/31/1969
A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Plaque Psoriasis Clinical Trial
Updated: 12/31/1969
A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Plaque Psoriasis Clinical Trial
Updated: 12/31/1969
A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Plaque Psoriasis Clinical Trial
Updated: 12/31/1969
A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Plaque Psoriasis Clinical Trial
Updated: 12/31/1969
Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Vulgaris Clinical Trial
Updated: 12/31/1969
To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis).
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Psoriasis Vulgaris Clinical Trial
Updated: 12/31/1969
To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis).
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
